|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/12/2024 |
$4.27 |
$4.30 |
$4.08 |
$4.12 |
762.90K | 04/15/2024 |
$4.12 |
$4.16 |
$4.01 |
$4.06 |
787.20K | 04/16/2024 |
$4.02 |
$4.08 |
$3.99 |
$4.05 |
790.20K | 04/17/2024 |
$5.42 |
$5.67 |
$4.99 |
$5.24 |
24.04M | 04/18/2024 |
$5.16 |
$5.25 |
$4.89 |
$4.97 |
3.86M |
|
Vanda Pharmaceuticals is a biopharmaceutical company. Co.'s commercial portfolio is comprised of two products, HETLIOZ® for the treatment of Non-24 Sleep-Wake Disorder (Non-24) and nighttime sleep disturbances in Smith-Magenis Syndrome and Fanapt® for the treatment of schizophrenia. In addition, Co. has a number of drugs in development, including: Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist, for the treatment of gastroparesis, motion sickness, atopic dermatitis, and COVID-19 pneumonia; and VTR-297, a small molecule histone deacetylase inhibitor for the treatment of hematologic malignancies and with potential use as a treatment for several oncology indications. | |
|
Vanda Pharmaceuticals (VNDA) has the following price history information. Looking back at VNDA historical stock prices for the last five trading days, on April 12, 2024, VNDA opened at $4.27, traded as high as $4.30 and as low as $4.08, and closed at $4.12. Trading volume was a total of 762.90K shares. On April 15, 2024, VNDA opened at $4.12, traded as high as $4.16 and as low as $4.01, and closed at $4.06. Trading volume was a total of 787.20K shares. On April 16, 2024, VNDA opened at $4.02, traded as high as $4.08 and as low as $3.99, and closed at $4.05. Trading volume was a total of 790.20K shares. On April 17, 2024, VNDA opened at $5.42, traded as high as $5.67 and as low as $4.99, and closed at $5.24. Trading volume was a total of 24.04M shares. On April 18, 2024, VNDA opened at $5.16, traded as high as $5.25 and as low as $4.89, and closed at $4.97. Trading volume was a total of 3.86M shares.
VNDA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Vanda Pharmaceuticals shares, starting with a $10,000 purchase of VNDA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$14.91 |
|
End price/share: |
$4.97 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-66.67% |
|
Average Annual Total Return: |
-10.41% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$3,332.16 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/12/2024 | $4.12 | 04/15/2024 | $4.06 | 04/16/2024 | $4.05 | 04/17/2024 | $5.24 | 04/18/2024 | $4.97 |
|
|